400
Participants
Start Date
February 10, 2025
Primary Completion Date
August 28, 2028
Study Completion Date
November 17, 2028
Cagrilintide
Participants will receive cagrilintide subcutaneously.
Semaglutide
Participants will receive semaglutide subcutaneously.
Placebo cagrilintide
Participants will receive placebo matched to cagrilintide subcutaneously.
Placebo semaglutide
Participants will receive placebo matched to semaglutide subcutaneously.
Cliniques Universitaires Saint-Luc - Serv Endocrinologie - Diabétologie, Brussels
UZA - UZ Antwerpen - Department of Endocrinology, Edegem
Hvidovre Hospital Endokrinologisk forsknings afsnit 159, Hvidovre
Center for Klinisk Metabolisk Forskning, Hellerup
UZ Leuven - Endocrinology, Leuven
Sjællands Universitetshospital, Køge
Sydvestjysk Sygehus Esbjerg, Esbjerg
CHU Helora - Hôpital de Mons - Site Constantinople, Mons
Aarhus Universitetshospital, Steno Diabetes Center Aarhus, Aarhus
Spartanburg Medical Research, Spartanburg
Holston Medical Group_Bristol, Bristol
L-MARC Research Center, Louisville
StudyMetrix Research LLC, City of Saint Peters
North Texas Endocrine Center, Dallas
Valley Clinical Trials, Covina
Diablo Clinical Research, Inc., Walnut Creek
East West Medical Research Institute_Honolulu, Honolulu
Yale University School Of Medicine, New Haven
Dr. M.B. Jones Inc, Victoria
Nova Scotia Health Authority, Halifax
Premier Clinical Trial Research Network (PCTRN), Hamilton
Alpha Recherche Clinique - Lebourgneuf, Québec
Unidade Local De Saude De Matosinhos E.P.E., Senhora Da Hora, Matosinhos
APDP - Associação Protectora dos Diabéticos de Portugal, Lisbon
CUF Descobertas, Lisbon
Hospital Cuf Descobertas S.A., Lisbon
Unidade Local de Saude de Sao Joao E.P.E, Porto
Hospital Luz Arrabida, S.A., Vila Nova de Gaia
Southmead Hospital, Bristol
Addenbrooke's Hospital_Cambridge, Cambridge
WISDEM Centre, Coventry
University Hospital Aintree, Liverpool
Blizard Institute_Royal London Hospital, London
Joint Clinical Research Facility - Swansea, Swansea
Musgrove Park Hospital, Taunton
Lead Sponsor
Novo Nordisk A/S
INDUSTRY